Latest news and articles about FDA from NEX English
Supira Medical has received approval from the FDA to initiate the SUPPORT II trial, aimed at assessing the effectiveness of a new heart support device. The trial will involve 385 patients across 40 sites in the United States.
The U.S. Food and Drug Administration (FDA) announced it will not clarify laws prohibiting the import of drugs from abroad, despite increasing evidence of alternative funding programs importing medications. These programs assist patients whose health plans do not cover expensive drugs.
Kintsugi, a California-based startup, has announced its closure after failing to obtain approval from the U.S. Food and Drug Administration (FDA) for its AI technology designed to detect signs of depression and anxiety through speech analysis. The company plans to release most of its technologies as open-source, allowing for use in other fields.
Eli Lilly has announced that its new drug 'Foundio' has received approval from the US Food and Drug Administration, paving the way for strong competition in the oral obesity medication market. This development comes as companies strive to provide effective solutions to the global obesity crisis.
Reports indicate that the U.S. Food and Drug Administration (FDA) intends to permit the production of 14 peptides that were previously banned due to safety concerns. This decision comes amid increasing calls for the use of these substances in medical treatments.
The U.S. Food and Drug Administration (FDA) has granted emergency approval for a new oral medication from Eli Lilly, making it the second daily medication available for obesity treatment. This approval is a significant step in addressing health issues related to weight.
The U.S. Food and Drug Administration (FDA) has granted fast approval for a new drug from Eli Lilly aimed at addressing obesity. This decision comes as many countries face rising obesity rates among their populations, raising significant public health concerns.
The U.S. Food and Drug Administration (FDA) has approved the weight loss drug "Fondue," developed by Eli Lilly. This decision comes at a time when effective solutions to combat obesity, a global health crisis, are increasingly needed.
The U.S. Food and Drug Administration has approved Eli Lilly's Foundayo pill, paving the way for a new entrant in the weight loss medication market. The new pill will be available to consumers at varying prices, reflecting increasing competition among manufacturers.
The U.S. Food and Drug Administration has announced a recall of chocolate products after discovering they contained undisclosed pharmaceutical ingredients. These substances pose a public health risk, especially for individuals taking heart medications.
Supplement manufacturers are urging the FDA to allow the use of new ingredients, including <strong>peptides</strong>, amid a growing demand for dietary supplements in the U.S. market. This push reflects a significant trend towards innovation in the health sector.